Epigenetics in Immune-Mediated Pulmonary Diseases
- 19 November 2013
- journal article
- review article
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 45 (3) , 314-330
Abstract
Immune-mediated pulmonary diseases are a group of diseases that resulted from immune imbalance initiated by allergens or of unknown causes. Inflammatory responses without restrictions cause tissue damage and remodeling, which leads to airway hyperactivity, destruction of alveolar architecture, and a resultant loss of lung function. Epigenetic mechanisms have been demonstrated to be involved in inflammation, autoimmunity, and cancer. Recent studies have identified that epigenetic changes also regulate molecular pathways in immune-mediated lung diseases. Aberrant DNA methylation status, dysregulation of histone modifications, as well as altered microRNAs expression could change transcription activity of genes involved in the development of immune-mediated pulmonary diseases, which contributes to skewed differentiation of T cells and proliferation and activation of myofibroblasts, leading to overproduction of inflammatory cytokines and excessive accumulation of extracellular matrix, respectively. Aside from this, epigenetics also explains how environmental exposure influence on gene transcription without genetic changes. It acts as a mediator of the interaction between environmental factors and genetic factors. Identification of the abnormal epigenetic marks in diseases provides novel biomarkers for prediction and diagnosis and affords novel therapeutic targets for those difficult clinical problems, such as steroid-resistance and rapidly progressing fibrosis. In this review, we summarized the latest experimental and translational epigenetic studies in immune-mediated pulmonary diseases, including asthma, idiopathic pulmonary fibrosis, tuberculosis, sarcoidosis, and silicosis.Keywords
This publication has 143 references indexed in Scilit:
- Microbial and human heat shock proteins as ‘danger signals’ in sarcoidosisHuman Immunology, 2013
- Maternal asthma and microRNA regulation of soluble HLA-G in the airwayJournal of Allergy and Clinical Immunology, 2013
- Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblastsCell Death & Disease, 2013
- An epigenetic silencing pathway controlling T helper 2 cell lineage commitmentNature, 2012
- Environmental epigenetics: prospects for studying epigenetic mediation of exposure–response relationshipsHuman Genetics, 2012
- Common patterns and disease-related signatures in tuberculosis and sarcoidosisProceedings of the National Academy of Sciences, 2012
- Epigenetics, Asthma, and Allergic Diseases: A Review of the Latest AdvancementsCurrent Allergy and Asthma Reports, 2012
- Participation of miR-200 in Pulmonary FibrosisThe American Journal of Pathology, 2012
- Environmental epigenetics of asthma: An updateJournal of Allergy and Clinical Immunology, 2010
- DNA methylation and methyl-CpG binding proteins: developmental requirements and functionChromosoma, 2009